1. Home
  2. BIAF vs MTR Comparison

BIAF vs MTR Comparison

Compare BIAF & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • MTR
  • Stock Information
  • Founded
  • BIAF 2014
  • MTR 1979
  • Country
  • BIAF United States
  • MTR United States
  • Employees
  • BIAF N/A
  • MTR N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MTR Oil & Gas Production
  • Sector
  • BIAF Health Care
  • MTR Energy
  • Exchange
  • BIAF Nasdaq
  • MTR Nasdaq
  • Market Cap
  • BIAF 14.5M
  • MTR 12.6M
  • IPO Year
  • BIAF 2022
  • MTR N/A
  • Fundamental
  • Price
  • BIAF $0.67
  • MTR $7.11
  • Analyst Decision
  • BIAF Strong Buy
  • MTR
  • Analyst Count
  • BIAF 1
  • MTR 0
  • Target Price
  • BIAF $6.00
  • MTR N/A
  • AVG Volume (30 Days)
  • BIAF 298.9K
  • MTR 12.8K
  • Earning Date
  • BIAF 11-14-2024
  • MTR 01-01-0001
  • Dividend Yield
  • BIAF N/A
  • MTR 2.96%
  • EPS Growth
  • BIAF N/A
  • MTR N/A
  • EPS
  • BIAF N/A
  • MTR 0.35
  • Revenue
  • BIAF $9,367,785.00
  • MTR $966,169.00
  • Revenue This Year
  • BIAF $285.51
  • MTR N/A
  • Revenue Next Year
  • BIAF $20.05
  • MTR N/A
  • P/E Ratio
  • BIAF N/A
  • MTR $20.18
  • Revenue Growth
  • BIAF 2813.87
  • MTR N/A
  • 52 Week Low
  • BIAF $0.64
  • MTR $5.60
  • 52 Week High
  • BIAF $3.62
  • MTR $11.99
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 26.36
  • MTR 65.09
  • Support Level
  • BIAF $0.64
  • MTR $6.35
  • Resistance Level
  • BIAF $1.01
  • MTR $6.91
  • Average True Range (ATR)
  • BIAF 0.07
  • MTR 0.33
  • MACD
  • BIAF -0.01
  • MTR 0.12
  • Stochastic Oscillator
  • BIAF 5.99
  • MTR 87.97

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About MTR Mesa Royalty Trust

Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.

Share on Social Networks: